Martin Gleave Explained

Dr. Martin Gleave is a Canadian surgeon and cancer researcher who was appointed to the Order of Canada in 2018.^[1]

Gleave is a co-founder and executive director of the Vancouver Prostate Centre as well as a head of a department at University of British Columbia.

Gleave's team was recognized in 2010 as the first in the world to develop an anti-clusterin agent.^[2]

Awards

• Richard D. Williams MD Prostate Cancer Research Excellence Award^[3]
• Eugene Fuller Triennial Prostate Award from the American Urological Association
• Barringer Medal from the American Association of Genitourinary Surgeons
• BC Biotech Innovation and Achievement Award
• BC Innovation Council Frontiers in Research Award
• 2013 Aubrey J. Tingle Prize from Michael Smith Foundation for Health Research^[4]

Notes and References

1. News: Li. Wanyee. B.C. doctor inducted into Order of Canada for innovative cancer treatments. January 10, 2018. Metro News Vancouver. January 4, 2018.
2. News: Crawford. Tiffany. New cancer drug will prolong lives, Vancouver scientists say. 9 January 2018. Vancouver Sun. August 28, 2010.
3. Web site: DR. MARTIN GLEAVE APPOINTED TO THE ORDER OF CANADA. Vancouver Coastal Health Research Institute. January 9, 2018.
4. Web site: AJT Prize Recognizes Made-In-BC Advances In Prostate Cancer Treatment. msfhr.org. January 9, 2018.